UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items: 146.

A

Adighibe, O; Arepalli, S; Duckworth, J; Hardy, J; Wavrant-De Vrieze, F; (2006) Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. NEUROBIOLOGY OF AGING , 27 (10) pp. 1431-1434. 10.1016/j.neurobiolaging.2005.08.010.

Anderson, VM; Fox, NC; Miller, DH; (2006) Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J MAGN RESON IMAGING , 23 (5) 605 - 618. 10.1002/jmri.20550.

Archer, HA; Edison, P; Brooks, DJ; Barnes, J; Frost, C; Yeatman, T; Fox, NC; (2006) Amyloid load and cerebral atrophy in Alzheimer's disease: An C-11-PIB positron emission tomography study. ANN NEUROL , 60 (1) 145 - 147. 10.1002/ana.20889.

Archer, HA; Edison, P; Fox, NC; Barnes, J; Frost, C; Yeatman, T; Brooks, DJ; (2006) Relationship between amyloid deposition and atrophy rates in Alzheimer's disease using C-11-PIB radiotracer. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 129 - 129). B M J PUBLISHING GROUP

Archer, HA; MacFarlane, F; Price, S; Moore, EK; Pepple, T; Cutler, D; Frost, C; ... Rossor, MN; + view all (2006) Do symptoms of memory impairment correspond to cognitive impairment: a cross sectional study of a clinical cohort. INT J GERIATR PSYCH , 21 (12) 1206 - 1212. 10.1002/gps.1644.

Asante, EA; Linehan, JM; Gowland, I; Joiner, S; Fox, K; Cooper, S; Osiguwa, O; ... Collinge, J; + view all (2006) Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. P NATL ACAD SCI USA , 103 (28) 10759 - 10764. 10.1073/pnas.0604292103. Gold open access

B

Barnes, J; Whitwell, JL; Frost, C; Josephs, KA; Rossor, M; Fox, NC; (2006) Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. ARCH NEUROL-CHICAGO , 63 (10) 1434 - 1439.

Berggren, U; Fahlke, C; Aronsson, E; Karanti, A; Eriksson, M; Blennow, K; Thelle, D; ... Balldin, J; + view all (2006) The TaqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small. ALCOHOL AND ALCOHOLISM , 41 (5) pp. 479-485. 10.1093/alcalc/agl043.

Bett, JS; Goellner, GM; Woodman, B; Pratt, G; Rechsteiner, M; Bates, GP; (2006) Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG gamma as a therapeutic target. HUMAN MOLECULAR GENETICS , 15 (1) pp. 33-44. 10.1093/hmg/ddi423.

Bjorkqvist, M; Petersen, A; Bacos, K; Isaacs, J; Norlen, P; Gil, J; Popovic, N; ... Mulder, H; + view all (2006) Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. HUM MOL GENET , 15 (10) 1713 - 1721. 10.1093/hmg/ddl094.

Blennow, K; de Leon, MJ; Zetterberg, H; (2006) Alzheimer's disease. LANCET , 368 (9533) pp. 387-403. 10.1016/S0140-6736(06)69113-7.

Bodi, I; Hortobagyi, T; Rossor, M; Lantos, PL; (2006) Suspected familial dementia with unexpected neuropathological findings. In: (pp. IX-X). SPRINGER WIEN

Boyes, RG; Rueckert, D; Aljabar, P; Whitwell, J; Schott, JM; Hill, DLG; Fox, NC; (2006) Cerebral atrophy measurements using Jacobian integration: Comparison with the boundary shift integral. NEUROIMAGE , 32 (1) 159 - 169. 10.1016/j.neuroimage.2006.02.052.

Bras, JM; Guerreiro, RJ; Morgadinho, AS; Januario, C; Oliveira, CR; Singleton, A; (2006) Genes and Parkinson's disease - A clinic-based study in a Portuguese cohort. In: MOVEMENT DISORDERS. (pp. S53 - S53). WILEY-LISS

Brooks, S; Daley, F; Johns, P; Brandner, S; Short, SC; (2006) Pescadillo and CYP1B1: Novel metabolic targets in glioma. In: RADIOTHERAPY AND ONCOLOGY. (pp. S72 - S73). ELSEVIER IRELAND LTD

Butler, R; Bates, GP; (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. NATURE REVIEWS NEUROSCIENCE , 7 (10) pp. 784-796. 10.1038/nrn1989.

C

Camara, O; Schweiger, M; Scahill, RI; Crum, WR; Sneller, BI; Schnabel, JA; Ridgway, GR; ... Fox, NC; + view all (2006) Phenomenological model of diffuse global and regional atrophy using finite-element methods. IEEE T MED IMAGING , 25 (11) 1417 - 1430. 10.1109/TMI.2006.880588.

Camara, O.; Schweiger, M.; Scahill, R.I.; Crum, W.R.; Sneller, B.I.; Schnabel, J.A.; Ridgway, G.R.; ... Fox, N.C.; + view all (2006) Phenomenological model of diffuse global and regional atrophy using finite-element methods. IEEE Transactions on Medical Imaging , 25 (11) pp. 1417-1430. 10.1109/TMI.2006.880588. Green open access
file

Campbell, WA; Yang, H; Zetterberg, H; Baulac, S; Sears, JA; Liu, TM; Wong, STC; ... Xia, WM; + view all (2006) Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. JOURNAL OF NEUROCHEMISTRY , 96 (5) pp. 1423-1440. 10.1111/j.1471-4159.2006.03648.x.

Clarimon, J; Scholz, S; Fung, HC; Hardy, J; Eerola, J; Hellstrom, O; Chen, CM; ... Singleton, A; + view all (2006) Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. AMERICAN JOURNAL OF HUMAN GENETICS , 78 (6) pp. 1082-1084. 10.1086/504727.

Cookson, MR; Hardy, J; (2006) Clinical implications of basic research: The persistence of memory. NEW ENGLAND JOURNAL OF MEDICINE , 355 (25) pp. 2697-2698. 10.1056/NEJMcibr065999.

Cordery, RJ; MacManus, D; Godbolt, A; Rossor, MN; Waldman, AD; (2006) Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. EUR RADIOL , 16 (8) 1692 - 1698. 10.1007/s00330-005-0090-4.

Crutch, SJ; (2006) Qualitatively different semantic representations for abstract and concrete words: Further evidence from the semantic reading errors of deep dyslexic patients. NEUROCASE , 12 (2) 91 - 97. 10.1080/13554790500507172.

Crutch, SJ; Ridha, BH; Warrington, EK; (2006) The different frameworks underlying abstract and concrete knowledge: Evidence from a bilingual patient with a semantic refractory access dysphasia. NEUROCASE , 12 (3) 151 - 163. 10.1080/13554790600598832.

Crutch, SJ; Rossor, MN; (2006) Artistic changes in Alzheimer's disease. In: UNSPECIFIED (147 - 161). ELSEVIER ACADEMIC PRESS INC

D

de Silva, R; Lashley, T; Strand, C; Shiarli, AM; Shi, J; Tian, JZ; Bailey, KL; ... Mann, DMA; + view all (2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies. ACTA NEUROPATHOL , 111 (4) 329 - 340. 10.1007/s00401-006-0048-x.

de Silva, R; Lashley, T; Strand, K; Shiarli, AM; Revesz, T; Mann, DMA; (2006) An immunohistochemical study of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific monoclonal tau antibodies. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 235 - 235). BLACKWELL PUBLISHING

E

Edison, P; Archer, H; Hinz, R; Fox, N; Brooks, DJ; (2006) Relationship between the distribution of microglial activation, amyloid plaque load and cerebral glucose metabolism in Alzheimer's disease (AD): An 11C-PK11195, 18F-FDG and 11C-PIB PET study. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. (pp. S6 - S7). BLACKWELL PUBLISHING

Edwards-Lee, T; Wen, J; Bell, J; Hardy, J; Chung, J; Momeni, P; (2006) A presenilin-1 mutation (T245P) in transmembrane domain 6 causes early onset Alzheimer's disease. NEUROSCIENCE LETTERS , 398 (3) pp. 251-252. 10.1016/j.neulet.2006.01.006.

F

Fidani, L; Kalinderi, K; Bostantjopoulou, S; Clarimon, J; Goulas, A; Katsarou, Z; Hardy, J; (2006) Association of the Tau haplotype with Parkinson's disease in the Greek population. MOVEMENT DISORDERS , 21 (7) pp. 1036-1039. 10.1002/mds.20864.

Fotaki, V; (2006) Abnormal Positioning of Diencephalic Cell Types in Neocortical Tissue in the Dorsal Telencephalon of Mice Lacking Functional Gli3. Journal of Neuroscience , 26 (36) pp. 9282-9292. 10.1523/JNEUROSCI.2673-06.2006.

Fox, N; (2006) Immunotherapy of AD: MR imaging of changes in brain morphology. In: NEUROBIOLOGY OF AGING. (pp. S8 - S8). ELSEVIER SCIENCE INC

Fox, NC; (2006) Neuroimaging in Alzheimer's disease. In: EUROPEAN NEUROPSYCHOPHARMACOLOGY. (pp. S197 - S198). ELSEVIER SCIENCE BV

Fung, HC; Chen, CM; Hardy, J; Hernandez, D; Singleton, A; Wu, YR; (2006) Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease. MOVEMENT DISORD , 21 (6) 880 - 881. 10.1002/mds.20814.

Fung, HC; Chen, CM; Hardy, J; Singleton, AB; Lee-Chen, GJ; Wu, YR; (2006) Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan. NEUROSCI LETT , 394 (1) 33 - 36. 10.1016/j.neulet.2005.10.005.

Fung, HC; Chen, CM; Hardy, J; Singleton, AB; Wu, YR; (2006) A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurology , 6 , Article 47. 10.1186/1471-2377-6-47. Green open access
file

Fung, HC; Scholz, S; Matarin, M; Simon-Sanchez, J; Hernandez, D; Britton, A; Gibbs, JR; ... Singleton, A; + view all (2006) Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. LANCET NEUROL , 5 (11) 911 - 916. 10.1016/S1474-4422(06)70578-6.

Fung, HC; Xiromerisiou, G; Gibbs, JR; Wu, YR; Eerola, J; Gourbali, V; Hellstrom, O; ... Singleton, AB; + view all (2006) Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts. NEURODEGENER DIS , 3 (6) 327 - 333. 10.1159/000097301.

Furby, J; Hayton, T; Smith, KJ; Altmann, D; Brenner, R; Chataway, J; Fox, NC; ... Kapoor, R; + view all (2006) A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S228 - S228). SAGE PUBLICATIONS LTD

G

Gandhi, S; Muqit, MMK; Abou-Sleiman, PM; Stanyer, L; Hargreaves, I; Heales, S; Ganguly, M; ... Revesz, T; + view all (2006) PINK1: a novel mitochondrial protein in Parkinson's disease. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 221 - 222). BLACKWELL PUBLISHING

Gandhi, S; Muqit, MMK; Stanyer, L; Healy, DG; Abou-Sleiman, PM; Hargreaves, I; Heales, S; ... Revesz, T; + view all (2006) PINK1 protein in normal human brain and Parkinson's disease. BRAIN , 129 1720 - 1731. 10.1093/brain/awl114.

Gandhi, S; Wood-Kaczmar, A; Jat, P; Latchman, DS; Tabrizi, SJ; Wood, NW; (2006) Investigation of PINK1 dysfunction in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S546 - S547). WILEY-LISS

Garcia, ML; Singleton, AB; Hernandez, D; Ward, CM; Evey, C; Sapp, PA; Hardy, J; ... Cleveland, DW; + view all (2006) Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. NEUROBIOLOGY OF DISEASE , 21 (1) pp. 102-109. 10.1016/j.nbd.2005.06.016.

Garrard, P; Schott, JM; MacManus, DG; Hodges, JR; Fox, NC; Waldman, AD; (2006) Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia. COGN BEHAV NEUROL , 19 (4) 185 - 189.

Garrard, P; Schott, JM; MacManus, DG; Hodges, JR; Fox, NC; Waldman, AD; (2006) Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia. Cognitive and Behavioral Neurology , 19 (4) pp.185-189.

Geddes, J; Mackay, C; Lloyd, S; Simpson, A; Power, D; Russell, D; Jirotka, M; ... Watson, G; + view all (2006) Designing for e-Health: Recurring Scenarios in Developing Grid-based Medical Imaging Systems. CHALLENGES AND OPPORTUNITIES OF HEALTHGRIDS , 120 336-+.

Geddes, J; Mackay, C; Lloyd, S; Simpson, A; Power, D; Russell, D; Katzarova, M; ... Watson, G; + view all (2006) The Challenges of developing a collaborative data and compute grid for Neurosciences. 19TH IEEE INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, PROCEEDINGS 81-+. 10.1109/CBMS.2006.156.

Geser, F; Wenning, GK; Seppi, K; Stampfer-Kountchev, M; Scherfler, C; Sawires, M; Frick, C; ... Bergquist, J; + view all (2006) Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA study group (EMSA SG). Movement Disorders , 21 (2) pp. 179-186. 10.1002/mds.20678.

Ghiso, J; Rostagno, A; Tomidokoro, Y; Lashley, T; Bojsen-Moller, M; Braendgaard, H; Plant, G; ... Frangione, B; + view all (2006) Genetic alterations of the BRI2 gene: Familial British and Danish dementias. BRAIN PATHOL , 16 (1) 71 - 79.

Godbolt, AK; Beck, JA; Collinge, JC; Cipolotti, L; Fox, NC; Rossor, MN; (2006) A second family with familial AD and the V717L APP mutation has a later age at onset. NEUROLOGY , 66 (4) 611 - 612.

Godbolt, AK; Waldman, AD; MacManus, DG; Schott, JM; Frost, C; Cipolotti, L; Fox, NC; (2006) MRS shows abnormalities before symptoms in familial Alzheimer disease. NEUROLOGY , 66 (5) 718 - 722.

Golding, CVP; Danchaivijitr, C; Hodgson, TL; Tabrizi, SJ; Kennard, C; (2006) Identification of an oculomotor biomarker of preclinical Huntington disease. NEUROLOGY , 67 (3) 485 - 487.

Gould, I; Chambers, CD; McNaught, E; Cunnington, R; Stuart, GW; Mattingley, JB; (2006) Magnetic stimulation of human frontal eye field modulates spatial attention and visual cortex activity. AUSTRALIAN JOURNAL OF PSYCHOLOGY , 58 p. 76.

Grupe, A; Li, YH; Rowland, C; Nowotny, P; Hinrichs, AL; Smemo, S; Kauwe, JSK; ... Goate, A; + view all (2006) A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. AMERICAN JOURNAL OF HUMAN GENETICS , 78 (1) pp. 78-88. 10.1086/498851.

Guerreiro, RJ; Bras, JM; Santana, I; Januario, C; Santiago, B; Morgadinho, AS; Ribeiro, MH; ... Oliveira, C; + view all (2006) Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurology , 6 , Article 24. 10.1186/1471-2377-6-24. Green open access
file

Guidetti, P; Bates, GP; Graham, RK; Hayden, MR; Leavitt, BR; MacDonald, ME; Slow, EJ; ... Schwarcz, R; + view all (2006) Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. NEUROBIOLOGY OF DISEASE , 23 (1) pp. 190-197. 10.1016/j.nbd.2006.02.011.

H

Hansson, O; Zetterberg, H; Buchhave, P; Londos, E; Blennow, K; Minthon, L; (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. LANCET NEUROLOGY , 5 (3) pp. 228-234. 10.1016/S1474-4422(06)70355-6.

Hardy, J; (2006) Amyloid double trouble. NATURE GENETICS , 38 (1) pp. 11-12. 10.1038/ng0106-11.

Hardy, J; (2006) Bad luck: An unappreciated limitation in the interpretation of twin studies. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS , 141B (6) p. 681. 10.1002/ajmg.b.30353.

Hardy, J; (2006) No definitive evidence for a role for the environment in the etiology of Parkinson's disease. MOVEMENT DISORDERS , 21 (10) pp. 1790-1791. 10.1002/mds.21067.

Hardy, J; (2006) A hundred years of Alzheimer's disease research. NEURON , 52 (1) 3 - 13. 10.1016/j.neuron.2006.09.016.

Hardy, J; Cai, H; Cookson, MR; Gwinn-Hardy, K; Singleton, A; (2006) Genetics of Parkinson's disease and parkinsonism. ANNALS OF NEUROLOGY , 60 (4) pp. 389-398. 10.1002/ana.21022.

Hardy, J; Cullen, K; (2006) Amyloid at the blood vessel wall. NATURE MEDICINE , 12 (7) pp. 756-757. 10.1038/nm0706-756.

Hardy, J; Momeni, P; Traynor, BJ; (2006) Frontal temporal dementia: dissecting the aetiology and pathogenesis. BRAIN , 129 pp. 830-831. 10.1093/brain/awl035.

Hardy, J; Orr, H; (2006) The genetics of neurodegenerative diseases. J NEUROCHEM , 97 (6) 1690 - 1699. 10.1111/j.1471-4159.2006.03979.x.

Hardy, J; Pittman, A; Myers, A; Fung, HC; de Silva, R; Duckworth, J; (2006) Tangle diseases and the tau haplotypes. ALZ DIS ASSOC DIS , 20 (1) 60 - 62.

Healy, DG; Abou-Sleiman, PM; Ahmadi, KR; Gandhi, S; Muqit, MM; Bhatia, KP; Quinn, NP; ... Wood, NW; + view all (2006) NR4A2 genetic variation in sporadic Parkinson's disease: A genewide approach. MOVEMENT DISORD , 21 (11) 1960 - 1963. 10.1002/mds.21018.

Healy, DG; Abou-Sleiman, PM; Casas, JP; Ahmadi, KR; Lynch, T; Gandhi, S; Muqit, MMK; ... Wood, NW; + view all (2006) UCHL-1 is not a Parkinson's disease susceptibility gene. ANN NEUROL , 59 (4) 627 - 633. 10.1002/ana.20757.

Henley, SMD; Frost, C; MacManus, DG; Warner, TT; Fox, NC; Tabrizi, SJ; (2006) Increased rate of whole-brain atrophy over 6 months in early Huntington disease. NEUROLOGY , 67 (4) 694 - 696.

Hockly, E; Tse, J; Barker, AL; Moolman, DL; Beunard, JL; Revington, AP; Holt, K; ... Bates, GP; + view all (2006) Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease. NEUROBIOLOGY OF DISEASE , 21 (1) pp. 228-236. 10.1016/j.nbd.2005.07.007.

Holmes, E; Tsang, TM; Tabrizi, SJ; (2006) The application of NMR-based metabonomics in neurological disorders. NeuroRx , 3 (3) pp. 358-372. 10.1016/j.nurx.2006.05.004.

Huey, ED; Grafman, J; Wassermann, EM; Pietrini, P; Tierney, MC; Ghetti, B; Spina, S; ... Momeni, P; + view all (2006) Characteristics of frontotemporal dementia patients with a progranulin mutation. ANNALS OF NEUROLOGY , 60 (3) pp. 374-380. 10.1002/ana.20969.

Hye, A; Lynham, S; Thambisetty, M; Causevic, M; Campbell, J; Byers, HL; Hooper, C; ... Lovestone, S; + view all (2006) Proteome-based plasma biomarkers for Alzheimer's disease. BRAIN , 129 3042 - 3050. 10.1093/brain/awl279.

I

Isaacs, AM; Senn, DB; Yuan, ML; Shine, JP; Yankner, BA; (2006) Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium. J BIOL CHEM , 281 (38) 27916 - 27923. 10.1074/jbc.M602061200. Gold open access

J

Jacques, TS; Eldridge, C; Patel, A; Saleem, NM; Powell, M; Kitchen, ND; Thom, M; (2006) Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. NEUROPATH APPL NEURO , 32 (2) 217 - 220. 10.1111/j.1365-2990.2005.00692.x.

Janssen, J-C.J.M.I.; (2006) Clinical, biochemical and neuroimaging studies in familial Alzheimer's disease. Doctoral thesis , University of London. Green open access
file

Jones, BF; Barnes, J; Uylings, HBM; Fox, NC; Frost, C; Witter, MP; Scheftens, P; (2006) Differential regional atrophy of the cingulate gyrus in Alzheimer disease: A volumetric MRI study. CEREB CORTEX , 16 (12) 1701 - 1708. 10.1093/cercor/bhj105.

K

Kerr, F; Rickle, A; Nayeem, N; Brandner, S; Cowburn, RF; Lovestone, S; (2006) PTEN, a negative regulator of P13 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS LETT , 580 (13) 3121 - 3128. 10.1016/j.febslet.2006.04.064.

Kidd, DP; Revesz, T; Miller, NR; (2006) Rosai-Dorfman disease presenting with widespread intracranial and spinal cord involvement. NEUROLOGY , 67 (9) 1551 - 1555.

Kilner, JM; Marchant, JL; Frith, CD; (2006) Modulation of the mirror system by social relevance. SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE , 1 (2) pp. 143-148. 10.1093/scan/nsl017.

Klunemann, H; Ridha, BH; Magy, L; Wherrett, JR; Hemelsoet, DM; Keen, RW; DeBleecker, JL; ... Paloneva, J; + view all (2006) The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2 - Reply. NEUROLOGY , 66 (4) 616 - 616.

L

Lashley, T; Holton, JL; Verbeek, MM; Rostagno, A; Bojsen-Moller, M; David, G; van Horssen, J; ... Revesz, T; + view all (2006) Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study. NEUROPATH APPL NEURO , 32 (5) 492 - 504. 10.1111/j.1365-2990.2006.00747.x.

Leow, AD; Klunder, AD; Jack, CR; Toga, AW; Dale, AM; Bernstein, MA; Britson, PJ; ... ADNI Preparatory Phase Study, ; + view all (2006) Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NEUROIMAGE , 31 (2) 627 - 640. 10.1016/j.neuroimage.2005.12.013.

Li, Y; Grupe, A; Rowland, C; Nowotny, P; Kauwe, JSK; Smemo, S; Hinrichs, A; ... Goate, A; + view all (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. HUMAN MOLECULAR GENETICS , 15 (17) pp. 2560-2568. 10.1093/hmg/ddl178.

M

Malkani, R; D'Souza, I; Gwinn-Hardy, K; Scheenberg, GD; Hardya, J; Momeni, P; (2006) A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia. NEUROBIOLOGY OF DISEASE , 22 (2) pp. 401-403. 10.1016/j.nbd.2005.12.001.

Marlowe, L; Peila, R; Benke, KS; Hardy, J; White, LR; Launer, LJ; Myers, A; (2006) Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk. NEURODEGENERATIVE DISEASES , 3 (6) pp. 320-326. 10.1159/000097300.

Masellis, M; Momeni, P; Meschino, W; Heffner, R; Elder, J; Sato, C; Liang, Y; ... Rogaeva, E; + view all (2006) Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. BRAIN , 129 pp. 3115-3123. 10.1093/brain/awl276.

Merikangas, KR; Low, NCP; Hardy, J; (2006) Commentary: Understanding sources of complexity in chronic diseases - the importance of integration of genetics and epidemiology. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY , 35 (3) pp. 590-592. 10.1093/ije/dyl007.

Milanesi, L; Hunter, CA; Sedelnikova, SE; Waltho, JP; (2006) Amplification of bifunctional ligands for calmodulin from a dynamic combinatorial library. CHEM-EUR J , 12 (4) 1081 - 1087. 10.1002/chem.200500357.

Momeni, P; Bell, J; Duckworth, J; Hutton, M; Mann, D; Brown, SP; Hardy, J; (2006) Sequence analysis of all identified open reading frames on the frontal temporal dementia haplotype on chromosome 3 fails to identify unique coding variants except in CHMP2B. NEUROSCIENCE LETTERS , 410 (2) pp. 77-79. 10.1016/j.neulet.2006.06.065.

Momeni, P; Rogaeva, E; Van Deerlin, V; Yuan, W; Grafman, J; Tierney, M; Huey, E; ... Hardy, J; + view all (2006) Genetic variability in CHMP2B and frontotemporal dementia. NEURODEGENERATIVE DISEASES , 3 (3) pp. 129-133. 10.1159/000094771.

Momeni, P; Schymick, J; Jain, S; Cookson, MR; Cairns, NJ; Greggio, E; Greenway, MJ; ... Traynor, BJ; + view all (2006) Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. BMC NEUROLOGY , 6 (ARTN 44) 10.1186/1471-2377-6-44. Gold open access

Muqit, MMK; Abou-Sleiman, PM; Saurin, AT; Harvey, K; Gandhi, S; Deas, E; Eaton, S; ... Latchman, DS; + view all (2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J NEUROCHEM , 98 (1) 156 - 169. 10.1111/j.1471-4159.2006.03845.x.

Murphy, DGM; Daly, E; Schmitz, N; Toal, F; Murphy, K; Curran, S; Erlandsson, K; ... Travis, M; + view all (2006) Cortical serotonin 5-HT(2A) receptor binding and social communication in adults with Asperger's syndrome: An in vivo SPECT study. AMERICAN JOURNAL OF PSYCHIATRY , 163 (5) pp. 934-936. 10.1176/appi.ajp.163.5.934.

N

Nayeem, N; Kerr, F; Naumann, H; Lovestone, S; Brandner, S; (2006) Hyperphosphorylation of tau and neurofilament by constitutive activation of CDK5 in PTEN deficient cerebellum. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 226 - 226). BLACKWELL PUBLISHING

O

Ozawa, T; Healy, DG; Abou-Sleiman, PM; Ahmadi, KR; Quinn, N; Lees, AJ; Shaw, K; ... European MSA Study Group, ; + view all (2006) The alpha-synuclein gene in multiple system atrophy. J NEUROL NEUROSUR PS , 77 (4) 464 - 467. 10.1136/jnnp.2005.073528.

P

Page, L; (2006) In Vivo<char aid="99756086" id="sup"> 1</char>H-Magnetic Resonance Spectroscopy Study of Amygdala-Hippocampal and Parietal Regions in Autism. American Journal of Psychiatry , 163 (12) p. 2189. 10.1176/appi.ajp.163.12.2189.

Paviour, DC; Price, SL; Jahanshahi, M; Lees, AJ; Fox, NC; (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. BRAIN , 129 1040 - 1049. 10.1093/brain/awl021.

Paviour, DC; Price, SL; Jahanshahi, M; Lees, AJ; Fox, NC; (2006) Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. MOVEMENT DISORD , 21 (7) 989 - 996. 10.1002/mds.20877.

Petzold, A; Keir, G; Fox, NC; Warren, J; (2006) The value of lumbar cerebrospinal fluid levels of neurofilaments in the differential diagnosis of patients with dementia. In: JOURNAL OF NEUROLOGY. (pp. 39 - 40). DR DIETRICH STEINKOPFF VERLAG

Portelius, E; Westman-Brinkmalm, A; Zetterberg, H; Blennow, K; (2006) Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. JOURNAL OF PROTEOME RESEARCH , 5 (4) pp. 1010-1016. 10.1021/pr050475v.

Portelius, E; Zetterberg, H; Andreasson, U; Brinkmalm, G; Andreasen, N; Wallin, A; Westman-Brinkmalm, A; (2006) An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. NEUROSCIENCE LETTERS , 409 (3) pp. 215-219. 10.1016/j.neulet.2006.09.044.

R

Rees, JH; Weil, RS; Waldman, AD; Jager, HR; Benton, CE; Tozer, DJ; Altman, DR; (2006) Gadolinium enhancement index predicts transformation in adult low-grade gliomas. EUR J NEUROL , 13 280 - 280.

Revesz, T; Ghiso, J; Plant, GT; Lashley, T; Rostagno, A; Frangione, B; Holton, JL; (2006) Cerebral Amyloid Angiopathy. In: Kalimo, H, (ed.) Cerebrovascular Diseases. (pp. 94-102). Wiley-Blackwell

Ridha, BH; Barnes, J; Bartlett, JW; Godbolt, A; Pepple, T; Rossor, MN; Fox, NC; (2006) Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. LANCET NEUROL , 5 (10) 828 - 834. 10.1016/S1474-4422(06)70550-6.

Rohrer, JD; Mead, S; Omar, R; Poulter, M; Warren, JD; Collinge, J; Rossor, MN; (2006) Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes. ANN NEUROL , 60 (5) 616 - 616. 10.1002/ana.20931.

Rohrer, JD; Smith, SJ; Warren, JD; (2006) Craving for music after treatment for partial epilepsy. EPILEPSIA , 47 (5) 939 - 940.

Rossor, MN; (2006) Potassium channel antibodies encephalopathy - A treatable dementia. EUR J NEUROL , 13 303 - 303.

S

Sampson, EL; Warren, JD; Rossor, MN; (2006) Young onset dementia. In: Morris, H, (ed.) Neurology update: reviews for continuing professional development. (pp. 215-248). Radcliffe Publishing: Oxford.

Schmitz, N; Rubia, K; Daly, E; Smith, A; Williams, S; Murphy, DGM; (2006) Neural correlates of executive function in autistic spectrum disorders. BIOLOGICAL PSYCHIATRY , 59 (1) pp. 7-16. 10.1016/j.biopsych.2005.06.007.

Schott, JM; (2006) Another case of voltage-gated potassium channel anti body-related encephalopathy? EUR NEUROL , 55 (2) 110 - 110. 10.1159/000092787.

Schott, JM; (2006) Limbic encephalitis: A clinician's guide. Practical Neurology , 6 (3) pp. 143-153. 10.1136/jnnp.2006.091827.

Schott, JM; Frost, C; Whitwell, JL; MacManus, DG; Boyes, RG; Rossor, MN; Fox, NC; (2006) Combining short interval MRI in Alzheimer's disease. J NEUROL , 253 (9) 1147 - 1153. 10.1007/s00415-006-0173-4.

Schott, JM; Ridha, BH; Crutch, SJ; Healy, DG; Uphill, JB; Warrington, EK; Rossor, MN; (2006) Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. ARCH NEUROL-CHICAGO , 63 (1) 155 - 156.

Schrag, A; Geser, F; StampferKountchev, M; Seppi, K; Sawires, M; Köllensperger, M; Scherfler, C; ... Berquist, J; + view all (2006) Health-related quality of life in multiple system atrophy. Movement Disorders , 21 (6) pp. 809-815. 10.1002/mds.20808.

Schrag, A; Schott, JM; (2006) Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. LANCET NEUROL , 5 (4) 355 - 363.

Seal, JL; Gornick, MC; Gogtay, N; Shaw, P; Greenstein, DK; Coffey, M; Gochman, PA; ... Addington, AM; + view all (2006) Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia. JOURNAL OF MEDICAL GENETICS , 43 (11) pp. 887-892. 10.1136/jmg.2006.043380.

Shatunov, A; Sambuughin, N; Jankovic, J; Elble, R; Lee, HS; Singleton, AB; Dagvadorj, A; ... Goldfarb, LG; + view all (2006) Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. BRAIN , 129 pp. 2318-2331. 10.1093/brain/awl120.

Sinha, TK; Miga, MI; Cash, DM; Weil, RJ; (2006) Intraoperative cortical surface characterization using laser range scanning: Preliminary results. NEUROSURGERY , 59 (4) pp. 368-376. 10.1227/01.NEU.0000222665.40301.D2.

Smemo, S; Nowotny, P; Hinrichs, AL; Kauwe, JSK; Cherny, S; Erickson, K; Myers, AJ; ... Goate, A; + view all (2006) Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. ANNALS OF NEUROLOGY , 59 (1) pp. 21-26. 10.1002/ana.20673.

Smith, APR; Stephan, KE; Rugg, MD; Dolan, RJ; (2006) Task and content modulate amygdala-hippocampal connectivity in emotional retrieval. NEURON , 49 (4) 631 - 638. 10.1016/j.neuron.2005.12.025.

Sneller, B; Garde, E; Atkinson, D; Batchelor, P; Fox, N; Hill, D; (2006) Flow artifacts in MR imaging for Alzheimer’s detection and progression. In: (Proceedings) Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders. (pp. S322-S323).

Sneller, B; Garde, E; Atkinson, D; Batchelor, P; Fox, NC; Hill, DLG; (2006) FLOW ARTIFACTS IN MR IMAGING FOR ALZHEIMER'S DETECTION AND PROGRESSION. In:

Stewart, L; von Kriegstein, K; Warren, JD; Griffiths, TD; (2006) Music and the brain: disorders of musical listening. BRAIN , 129 2533 - 2553. 10.1093/brain/awl171.

Stewart, L.; von Kriegstein, K.; Warren, J.D.; Griffiths, T.D.; (2006) Music and the brain: disorders of musical listening. Brain , 129 (10) pp. 2533-2553. 10.1093/brain/awl171.

T

Tai, YF; Pavese, N; Gerhard, A; Tabrizi, SJ; Barker, RA; Brooks, DJ; Piccini, P; (2006) Microglial activation in presymptomatic Huntington's disease gene carriers: A combined C-11-PK11195 and C-11-raclopride PET study. In: NEUROLOGY. (pp. A134 - A134). LIPPINCOTT WILLIAMS & WILKINS

Tai, YF; Pavese, N; Gerhard, A; Tabrizi, SJ; Barker, RA; Brooks, DJ; Piccini, P; (2006) Microglial activation in presymptomatic Huntington's disease gene carriers: A combined C-11-PK11195 and C-11-raclopride PET study. In: NEUROLOGY. (pp. A330 - A330). LIPPINCOTT WILLIAMS & WILKINS

Tarditi, A; Camurri, A; Varani, K; Borea, PA; Woodman, B; Bates, G; Cattaneo, E; (2006) Early and transient alteration of adenosine A(2A) receptor signaling in a mouse model of Huntington disease. NEUROBIOLOGY OF DISEASE , 23 (1) pp. 44-53. 10.1016/j.nbd.2006.01.014.

Thal, LJ; Kantarci, K; Reiman, EM; Klunk, WE; Weiner, MW; Zetterberg, H; Galasko, D; ... Siemers, E; + view all (2006) The role of biomarkers in clinical trials for Alzheimer disease. ALZHEIMER DISEASE & ASSOCIATED DISORDERS , 20 (1) pp. 6-15. 10.1097/01.wad.0000191420.61260.a8.

Tsang, TA; Woodman, B; McLoughlin, GA; Griffin, JL; Tabrizi, SJ; Bates, GP; Holmes, E; (2006) Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS H-1 NMR spectroscopy. J PROTEOME RES , 5 (3) 483 - 492. 10.1021/pr050244o.

V

Valente, E; Brady, JD; McGregor, L; Soutar, M; Vazquez, M; Wilson, L; (2006) Performance evaluation of an automated microparticle enzyme immunoassay (MEIA) for holo-transcobalamin, AxSYM (R) HoloTC. In: CLINICAL CHEMISTRY. (pp. A179 - A179). AMER ASSOC CLINICAL CHEMISTRY

van der Flier, WM; Schoonenboom, SNM; Pijnenburg, YAL; Fox, NC; Scheltens, P; (2006) The effect of APOE genotype on clinical phenotype in Alzheimer disease. NEUROLOGY , 67 (3) 526 - 527. 10.1212/01.wnl.0000228222.17111.2a.

von Kriegstein, K; Warren, JD; Ives, DT; Patterson, RD; Griffiths, TD; (2006) Processing the acoustic effect of size in speech sounds. NEUROIMAGE , 32 (1) 368 - 375. 10.1016/j.neuroimage.2006.02.045.

W

Wadsworth, JDF; Joiner, S; Linehan, JM; Cooper, S; Powell, C; Mallinson, G; Buckell, J; ... Collinge, J; + view all (2006) Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. BRAIN , 129 1557 - 1569. 10.1093/brain/awl076.

Warren, JD; (2006) On selection of medical students: a personal response. INTERN MED J , 36 (5) 334 - 334. 10.1111/j.1445-5994.2006.01067.x.

Warren, JD; Schott, GD; (2006) Musical hallucinations in a musician. J NEUROL , 253 (8) 1097 - 1099. 10.1007/s00415-006-0167-2.

Warren, JD; Scott, SK; Price, CJ; Griffiths, TD; (2006) Human brain mechanisms for the early analysis of voices. NEUROIMAGE , 31 (3) 1389 - 1397. 10.1016/j.neuroimage.2006.01.034.

Weil, RS; Cohen, JM; Portarena, I; Brada, M; (2006) Optimal dose of stereotactic radiosurgery for acoustic neuromas: a systematic review. BRITISH JOURNAL OF NEUROSURGERY , 20 (4) pp. 195-202. 10.1080/02688690600886108.

Wild, E; (2006) The neurological significance of deja vu. Current Medical Literature - Neurology , 22 (1) pp. 1-9.

Wild, EJ; Tabrizi, SJ; (2006) Predict-HD and the future of therapeutic trials. LANCET NEUROL , 5 (9) 724 - 725.

Wood-Kaczmar, A; Gandhi, S; Jat, P; Miljan, EA; Sinden, J; Keen, GJ; Taylor, J; ... Tabrizi, SJ; + view all (2006) Generation of a cellular model of PINK1 parkinsonism in primary human dopaminergic neurons. In: MOVEMENT DISORDERS. (pp. S546 - S546). WILEY-LISS

Wood-Kaczmar, A; Gandhi, S; Wood, NW; (2006) Understanding the molecular causes of Parkinson's disease. TRENDS MOL MED , 12 (11) 521 - 528. 10.1016/j.molmed.2006.09.007.

Wroe, SJ; Pal, S; Siddique, D; Hyare, H; Macfarlane, R; Joiner, S; Linehan, JM; ... Collinge, J; + view all (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. LANCET , 368 (9552) 2061 - 2067.

Z

Zetterberg, H; Blennow, K; (2006) Plasma A beta in Alzheimer's disease - up or down? LANCET NEUROLOGY , 5 (8) pp. 638-639. 10.1016/S1474-4422(06)70503-8.

Zetterberg, H; Campbell, WA; Yang, HW; Xia, WM; (2006) The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis. JOURNAL OF BIOLOGICAL CHEMISTRY , 281 (17) pp. 11933-11939. 10.1074/jbc.M512521200.

Zetterberg, H; Hietala, MA; Jonsson, M; Andreasen, N; Styrud, E; Karlsson, I; Edman, A; ... Wallin, A; + view all (2006) Neurochemical aftermath of amateur boxing. ARCHIVES OF NEUROLOGY , 63 (9) pp. 1277-1280. 10.1001/archneur.63.9.1277.

This list was generated on Sun Dec 9 04:18:21 2018 GMT.